Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Price Plan

Do pricing controls benefit healthcare systems? Whether or not they agree, pharma companies must adopt a collaborative approach in order to implement the latest amendments to the Pharmaceutical Price Regulation Scheme successfully

Chris Stirling and Lizzie Tuckey, KPMG (December 2013)

Keywords: Pharmaceutical Price Regulation Scheme (PPRS), Spending cap, Value-based pricing (VBP)

    View full article    |    Back to Industry Insight section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |